Diabetes Research and Clinical Practice
Volume 87, Issue 2 , Pages 157-160, February 2010

Plasma sRAGE is not associated with urinary microalbumin excretion in type 2 diabetic nephropathy at the early stage

The Department of Endocrinology, Jiangsu Province Hospital of TCM, 155 Han-Zhong Road, Nanjing 210029, Jiangsu, China

Received 22 June 2009; received in revised form 27 October 2009; accepted 2 November 2009. published online 30 November 2009.

Abstract 

Aims

The interaction of advanced glycation end products (AGEs) and the receptor for advanced glycation end products (RAGE) has played an important role in the pathogenesis of diabetic nephropathy. In the present study, we measured the relationship of plasma soluble isoform of RAGE (sRAGE) and urinary microalbumin excretion in the early stage of type 2 diabetic nephropathy.

Methods

180 patients with early stage of type 2 diabetic nephropathy were recruited into the study. Plasma sRAGE and the characterized AGE carboxymethyllysine (CML) were measured by enzyme-linked immunosorbent assay.

Results

Plasma sRAGE positively correlated with the level of CML (R=0.22, P=0.03) while sRAGE was not significantly correlated with the urinary mAlb/Cr (R=0.15, P=NS). On stepwise linear regression analysis, AGE and GFR were the main independent determinants of plasma sRAGE concentration.

Conclusion

Plasma sRAGE is not significantly associated with urinary microalbumin excretion in the early stage of diabetic nephropathy while it is correlated positively with circulating AGE and negatively with glomerular filtration rate (GFR).

Abbreviations: AGEs, advanced glycation end products, RAGE, receptor for advanced glycation end products, GFR, glomerular filtration rate, SBP, systolic blood pressure, DBP, diastolic blood pressure, CML, carboxymethyllysine ;mAlb/Crthe ratio of urinary microalbumin to creatinine

Keywords: Diabetic nephropathy, sRAGE, Carboxymethyllysine, Urinary microalbumin

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0168-8227(09)00473-2

doi:10.1016/j.diabres.2009.11.002

Diabetes Research and Clinical Practice
Volume 87, Issue 2 , Pages 157-160, February 2010